NCT06725160

Brief Summary

The goal of this mechanistic clinical trial is to examine whether parent-coaching aimed at increasing child positive affect will increase child neural response to reward. The main questions it aims to answer are: Aim 1. Characterize child neural reward response and its relation to maternal socialization of positive emotions at baseline in healthy young children. Aim 2. Evaluate how coaching-related changes in maternal socialization of positive emotion expression contribute to increases in child neural reward response over time. Aim 3. Examine how maternal socialization of positive emotion expression contributes to increases in child neural reward response in the moment. Participating mother-child dyads will be randomized to either 3 sessions of parent coaching of child positive affect or 3 sessions of a general parenting support intervention and neural response to reward and affective behavior will be examined pre and post intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for not_applicable depression

Timeline
34mo left

Started Oct 2025

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Oct 2025Feb 2029

First Submitted

Initial submission to the registry

December 5, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 10, 2024

Completed
11 months until next milestone

Study Start

First participant enrolled

October 28, 2025

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2029

Last Updated

January 28, 2026

Status Verified

January 1, 2026

Enrollment Period

3.3 years

First QC Date

December 5, 2024

Last Update Submit

January 26, 2026

Conditions

Keywords

depressionrewardneuralbehaviorparentearly childhood

Outcome Measures

Primary Outcomes (1)

  • Reward Positivity (RewP)

    The Reward Positivity (RewP) ERP component of the EEG signal is the mean amplitude (μV; microvolt) on gain-loss trials during receipt of reward related feedback in a computerized reward task with higher RewP amplitudes indicating greater reward response (i.e., more favorable outcome).

    From baseline week 1 to final assessment week 5 (week 10 maximum)

Secondary Outcomes (3)

  • Parent Responses to Child Positive affect Scale (PRCPS)

    From baseline week 1 to final assessment week 5 (week 10 maximum)

  • Behavioral Coding of Parental Encouragement of Child Positive Emotion

    From baseline week 1 to final assessment week 5 (week 10 maximum)

  • Late Positive Potential (LPP)

    From baseline week 1 to final assessment week 5 (week 10 maximum)

Study Arms (2)

Parent Coaching

EXPERIMENTAL

Parents will receive 3 sessions based on PCIT-ED aimed at increasing child positive affect.

Behavioral: Parent Coaching

Active Control

ACTIVE COMPARATOR

Parents will receive 3 sessions based on traditional PCIT providing more general parenting supporting, including basic psychoeducation and parenting skills.

Behavioral: Active Control

Interventions

Parent CoachingBEHAVIORAL

Three sessions of parent coaching of child positive affect will be administered based on modules from PCIT-ED.

Also known as: PCIT-ED
Parent Coaching
Active ControlBEHAVIORAL

General parent support and psychoeducation based on components of standard PCIT.

Active Control

Eligibility Criteria

Age4 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Birth mother (biologically female, any gender)
  • Providing regular care for participating child (i.e., at least 50% of time)
  • Elevated, clinically significant levels of depression (16 or higher on CES-D)
  • Aged 18+

You may not qualify if:

  • Lifetime history of a bipolar disorder
  • Lifetime history of a psychotic disorder
  • Aged 4-6 years
  • T-score greater than 63 on the internalizing or externalizing composites of the CBCL
  • Lifetime history of a psychiatric illness
  • Lifetime history of neurodevelopmental disorder
  • Lifetime history of neurological disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

RECRUITING

MeSH Terms

Conditions

DepressionBehavior

Condition Hierarchy (Ancestors)

Behavioral Symptoms

Study Officials

  • Judith M Morgan, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR
  • Lauren M. Bylsma, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Julie Research Coordinator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 5, 2024

First Posted

December 10, 2024

Study Start

October 28, 2025

Primary Completion (Estimated)

February 1, 2029

Study Completion (Estimated)

February 1, 2029

Last Updated

January 28, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Data will be shared with the NIH NDA per NIH requirements, which include all primary study measures and demographic information. Participant identifying information is used to create an anonymized GUID to identify participants in the NDA but no identifiable information will be shared publicly.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
We will begin to upload data to the NIH NDA beginning in July 2025 per NIMH requirements, which would then be made publicly available by November 2025. Data in the NDA will be made available indefinitely as long as the NDA exists as a resource.
Access Criteria
Informed consent documents, protocol information, and statistical analysis plan information will all be uploaded to clinicaltrials.gov. Access to participant level data will be managed by the NIH National Data Archive where all the individual participant data and supporting information will be uploaded. Additional data regarding statistical analyses and corresponding code will be provided as supplemental material to publications that use this data. Since this is a mechanistic clinical trial and not an RCT, a CSR is not applicable.
More information

Locations